Cardiotoxicity from neoadjuvant targeted treatment for breast cancer prior to surgery

HIGHLIGHTS

• who: Yihua Liu from the Memorial Hospital, China University, China have published the research: Cardiotoxicity from neoadjuvant targeted treatment for breast cancer prior to surgery, in the Journal: (JOURNAL)
• how: This paper describes the causative mechanisms risk factors monitoring tools and interventions for cardiovascular toxicity associated with preoperative neoadjuvant targeted therapy in BC patients based on recent medical evidence. Follow-up data indicated that all patients achieved complete remission of any cardiac symptoms and their LVEF returned to normal levels .
• future: Future research should focus on the cardiovascular safety of patients with impaired . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.